Cargando…
Metformin use and cardiovascular outcomes in patients with diabetes and chronic kidney disease: a nationwide cohort study
BACKGROUND: Metformin has recently been shown not to increase the risk of lactic acidosis in patients with chronic kidney disease (CKD). Thus, the criteria for metformin use in this population has expanded. However, the relationship between metformin use and clinical outcomes in CKD remains controve...
Autores principales: | Kim, Min-Ho, Oh, Hyung Jung, Kwon, Soon Hyo, Jeon, Jin Seok, Noh, Hyunjin, Han, Dong Cheol, Kim, Hyoungnae, Ryu, Dong-Ryeol |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Society of Nephrology
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8685353/ https://www.ncbi.nlm.nih.gov/pubmed/34922433 http://dx.doi.org/10.23876/j.krcp.20.222 |
Ejemplares similares
-
Age and sex specific target of blood pressure for the prevention of cardiovascular event among the treatment naive hypertensive patients
por: Kim, Hyoungnae, et al.
Publicado: (2020) -
Metformin inhibits chronic kidney disease‐induced DNA damage and senescence of mesenchymal stem cells
por: Kim, Hyoungnae, et al.
Publicado: (2021) -
Sirt1–hypoxia‐inducible factor‐1α interaction is a key mediator of tubulointerstitial damage in the aged kidney
por: Ryu, Dong Ryeol, et al.
Publicado: (2019) -
Association between blood pressure and the risk of chronic kidney disease in treatment-naïve hypertensive patients
por: Lee, Haekyung, et al.
Publicado: (2022) -
Impaired fasting glucose and development of chronic kidney disease in non-diabetic population: a Mendelian randomization study
por: Kim, Hyoungnae, et al.
Publicado: (2020)